{
    "organizations": [],
    "uuid": "8330fdca2cc7536602c72a6869ef4fe9d902279a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fda-grants-orphan-drug-designation/brief-fda-grants-orphan-drug-designation-for-protagonist-therapeutics-ptg-300-idUSASB0C936",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Grants Orphan Drug Designation For Protagonist Therapeutics' PTG-300",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - Protagonist Therapeutics Inc:\n* FDA GRANTS ORPHAN DRUG DESIGNATION FOR PROTAGONIST THERAPEUTICSâ€™ PTG-300 FOR THE TREATMENT OF BETA-THALASSEMIA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-07T05:55:00.000+02:00",
    "crawled": "2018-03-07T19:32:09.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "protagonist",
        "therapeutic",
        "inc",
        "fda",
        "grant",
        "orphan",
        "drug",
        "designation",
        "protagonist",
        "therapeutic",
        "treatment",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}